List view / Grid view
1 October 2014 | By Cardio3 BioSciences
Cardio3 BioSciences announces that it has recently increased its business development activities, building on its core expertise in cellular therapies and in cardiovascular diseases...
1 October 2014 | By Avacta Life Sciences
Avacta Life Sciences is investing £10m in the launch of Affimers, the engineered alternative to antibodies...
30 September 2014 | By Roche
Roche and InterMune, Inc. announced that Roche’s wholly owned subsidiary Klee Acquisition Corporation has accepted for payment all shares validly tendered pursuant to its tender offer for all outstanding shares of common stock of InterMune, Inc. at USD 74.00 per share in cash...
30 September 2014 | By Daiichi Sankyo
Lead compound, Quizartinib, will further build Daiichi Sankyo oncology pipeline...
29 September 2014 | By Horizon Discovery Group
Horizon Discovery Group plc announced it has agreed to acquire Sage Labs Inc...
29 September 2014 | By Caris Life Sciences
Caris Life Sciences announced important new data presented at the European Society for Medical Oncology Annual Conference, highlighting how tumour profiling with Caris Molecular Intelligence can help transform cancer care...
29 September 2014 | By Kymab
Following a US$40 million Series B investment from The Wellcome Trust and the Bill & Melinda Gates Foundation...
29 September 2014 | By SIGMOID PHARMA LIMITED
SIGMOID PHARMA LIMITED and Pendopharm have entered into agreements concerning a licence for exclusive rights to commercialise CyCol® in the Canadian market and an equity investment in SIGMOID...
26 September 2014 | By EATRIS
EATRIS has signed a formal framework agreement with the Roche Partnering Extending Innovation Network (EIN) program...
26 September 2014 | By Pfizer
Pfizer Inc. announced that it has completed its acquisition of the pharmaceutical development company, InnoPharma, Inc., following receipt of United States (U.S.) regulatory approval from all government authorities required by the agreement and other closing conditions...
25 September 2014 | By Ecolab
Recent guidelines aimed at raising standards of contamination control in the pharmaceutical industry mean organisations need to assess their current practices...
25 September 2014 | By SGS Life Science Services
SGS Life Science Services announced the the completion of its fifth North American Life Science Services laboratory, in Carson, California...
25 September 2014 | By TXCELL
TxCell reports its financial results for the first half of 2014...
25 September 2014 | By Horizon Discovery
Agreement covers development of molecular reference standards for companion diagnostics...
25 September 2014 | By Probiodrug
Probiodrug AG announces its intention to raise new funds through an Initial Public Offering and listing on Euronext Amsterdam...
